Reversible inhibition of human SGLT1 and SGLT2 currents
Cell-based study · HEK293T cells transiently expressing hSGLT1 or hSGLT2; whole-cell patch clamp at 37°C and −60 mV [1]
Extracellular phlorizin inhibited both human transporters. Ki was estimated from concentration-dependent current inhibition near the glucose K0.5 under a competitive-inhibition assumption. Washout showed slower recovery for hSGLT2. Direct association kinetics could not be resolved because of solution-change speed.
| Endpoint | Reported result | Reference |
|---|---|---|
| Inhibition of glucose-induced current | Ki hSGLT2: 11 ± 0.9 nM; hSGLT1: 140 ± 15 nM (means ± SE; n ≥ 3 cells) | [1] |
| Recovery of glucose current after external phlorizin removal | t1/2,Off hSGLT2: 24 ± 3 s; hSGLT1: 4 ± 0.5 s (means ± SE; n ≥ 3 cells) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Varied extracellular phlorizin for Ki estimation; 1 μM for Figure 7 wash-in/washout records
- Exposure duration
- Acute perfusion and washout; no fixed exposure interval given for Ki estimation
- Method
- Whole-cell glucose-induced current recording. Ki estimation used 5 mM glucose for hSGLT2 and 2 mM for hSGLT1; Figure 7 time courses used 100 mM and 2 mM glucose, respectively.
- Vehicle
- Extracellular recording buffer; compound stock solvent not specified in cited methods
- Co-treatment
- Glucose is the transported substrate, not a second inhibitor.
- Reported limits
- Compound-specific purity, lot and hydration state are not specified in Reagents; total exposure time for each concentration is not specified in the cited inhibition methods.
Methods and source locations
Compound reported in the paper: Phlorizin (Phloridzin); Compound label in the paper: Phlorizin
Human transporter assays using paper-tested material; reported assay constants are model-dependent.
Materials and Methods: Whole cell patch-clamp recordings; Phlorizin inhibition, Eqs. 6–8 (with corrigendum); Results: Phlorizin inhibition; Table 1; Figure 7
Inhibition of glucose-induced current: Estimated from IC50 near glucose K0.5, assuming competitive inhibition; 37°C, −60 mV. These are assay constants, not treatment doses. — Table 1, Ki phlorizin row and footnote; Methods Eq. 6; Results: Phlorizin inhibition
Recovery of glucose current after external phlorizin removal: Single-exponential fits to washout recovery. Figure 7 individual traces show 29 s and 3.8 s, distinct from Table 1 group means. — Table 1, t1/2,Off phlorizin row and footnote; Figure 7 and caption